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A B S T R A C T
Background: Neuroimaging studies have demonstrated gray matter (GM) volume abnormalities in substance
users. While the majority of substance users are polysubstance users, very little is known about the relation
between GM volume abnormalities and polysubstance use.
Methods: In this study we assessed the relation between GM volume, and the use of alcohol, tobacco, cocaine and
cannabis as well as the total number of substances used, in a sample of 169 males: 15 non-substance users, 89
moderate drinkers, 27 moderate drinkers who also smoke tobacco, 13 moderate drinkers who also smoke to-
bacco and use cocaine, 10 heavy drinkers who smoke tobacco and use cocaine and 15 heavy drinkers who smoke
tobacco, cannabis and use cocaine.
Results: Regression analyses showed that there was a negative relation between the number of substances used
and volume of the dorsal medial prefrontal cortex (mPFC) and the ventral mPFC. Without controlling for the use
of other substances, the volume of the dorsal mPFC was negatively associated with the use of alcohol, tobacco,
and cocaine. After controlling for the use of other substances, a negative relation was found between tobacco and
cocaine and volume of the thalami and ventrolateral PFC, respectively.
Conclusion: These ﬁndings indicate that mPFC alterations may not be substance-speciﬁc, but rather related to the
number of substances used, whereas, thalamic and ventrolateral PFC pathology is speciﬁcally associated with
tobacco and cocaine use, respectively. These ﬁndings are important, as the diﬀerential alterations in GM volume
may underlie diﬀerent cognitive deﬁcits associated with substance use disorders.
1. Introduction
Voxel-based morphometry (VBM) studies have demonstrated large
scale gray matter (GM) volume abnormalities in substance users, in-
cluding tobacco users (Hanlon et al., 2016; Wetherill et al., 2015; Zhong
et al., 2016), heavy alcohol users (Xiao et al., 2015; Yang et al., 2016),
cannabis users (Cousijn et al., 2012; Wetherill et al., 2015) and cocaine
users (Crunelle et al., 2014; Ide et al., 2014; Rando et al., 2013).
However, a large portion of substance users are polysubstance users,
using more than one type of drug simultaneously or at diﬀerent
moments close in time (Connor et al., 2014; European Monitoring
Centre for Drugs and Drug Addiction, 2009). Despite the high pre-
valence and poor treatment outcomes associated with polysubstance
use disorders (Dutra et al., 2008), little is known about neurobiological
pathways associated with polysubstance use.
Importantly, most studies in this ﬁeld focus on the relation between
GM volume and the use of one particular substance, without controlling
for the use of other substances. For instance, two recent meta-analyses
demonstrated that GM volume of the prefrontal cortex (PFC) is nega-
tively related to lifetime alcohol consumption (Yang et al., 2016) and
https://doi.org/10.1016/j.drugalcdep.2018.03.010
Received 6 December 2017; Received in revised form 12 February 2018; Accepted 6 March 2018
⁎ Corresponding author at: Department of Psychology, Addiction, Development and Psychopathology (ADAPT) Lab, University of Amsterdam, The Netherlands.
E-mail address: a.m.kaag@uva.nl (A.M. Kaag).
Drug and Alcohol Dependence 187 (2018) 186–194
Available online 15 April 2018
0376-8716/ © 2018 Elsevier B.V. All rights reserved.
T
lifetime tobacco consumption (Zhong et al., 2016), without taking into
account other substances of abuse reported by the participants. More-
over, despite the fairly consistent ﬁnding of a negative relationship
between PFC volume and lifetime exposure to alcohol or tobacco, stu-
dies in cocaine users are far less consistent: while some studies in co-
caine users report a negative association between the level of cocaine
exposure and PFC volumes (Alia-Klein et al., 2011; Barrós-Loscertales
et al., 2011; Ersche et al., 2011; Lim et al., 2008; Makris et al., 2008;
Rando et al., 2013), other studies failed to do so (Crunelle et al., 2014;
Franklin et al., 2002; Hanlon et al., 2011; Kaag et al., 2014; Matochik
et al., 2003; Narayana et al., 2010). Similar inconsistencies have been
demonstrated in cannabis users, as some studies suggest that volume of
the amygdala and hippocampus are negatively related to lifetime can-
nabis use (Cousijn et al., 2012; Demirakca et al., 2011b), whereas an-
other did not ﬁnd this association (Haller et al., 2013). Interactions
between the use of diﬀerent types of substances (Althobaiti and Sari,
2016; Jutkiewicz et al., 2008; Lopes et al., 2012; Valjent et al., 2002;
Wheeler et al., 2008) may explain these inconsistent ﬁndings.
In an attempt to take polysubstance use into account, several studies
applied multiple regression analyses to test for the speciﬁc relation
between a certain substance and GM volume, controlling for the po-
tential confounding eﬀects of others substances. These studies demon-
strated that GM alterations in regular cocaine users are unrelated to co-
occurring amphetamine use (Mackey et al., 2014), tobacco or alcohol
use (Crunelle et al., 2014; Kaag et al., 2014). In contrast, smaller tha-
lamic volumes in opioid-dependent patients were explained by co-oc-
curring alcohol use (Reid et al., 2008). However, multiple regression
analyses only allow one to estimate the speciﬁc relation between GM
volume and a certain substance, controlling for the use of other sub-
stances, but it is unable to estimate the relation between the combined
use of substances (as in polysubstance use) and GM volume. One way to
estimate eﬀects of multiple substances is to use the number of diﬀerent
substances that were used as a regressor in the analyses, as an esti-
mation of the relation between polysubstance use and GM volume.
Using this method, we recently demonstrated that white matter in-
tegrity of the PFC is unrelated to the use of one speciﬁc substance, but is
strongly (negatively) related to the number of substance used in a linear
fashion (Kaag et al., 2016b). Similarly, others have demonstrated that
structural abnormalities in the PFC are more profound in amphetamine
users with a history of co-occurring heavy alcohol use compared to
those without (Lawyer et al., 2010); in polysubstance users who smoke,
compared to those who do not smoke (Pennington et al., 2015); and in
polysubstance users compared to non-polysubstance using alcohol-de-
pendent patients (Pennington et al., 2015). These studies support the
hypothesis that structural abnormalities in the PFC are not substance-
speciﬁc, but more generally related to the number of substances used.
Here we extend on these previous ﬁnding, by studying GM volume
in a larger sample, ranging from non-substance users to individuals who
use any combination of alcohol, tobacco, cocaine and cannabis, instead
of comparing only two groups of substance users as has been done in
the previous studies. Structural MRI scans were collected as part of
other studies (Jansen et al., 2015; Kaag et al., 2016a; Schulte et al.,
2017), acquired on the same scanner and using the same MRI sequence.
All subjects were classiﬁed according to the number of substances used
and this number was subsequently used in a whole brain regression
analyses to test the relation between the number of substances used and
GM diﬀerences. In line with previous work, it was expected that the
number of substances used was negatively and linearly related to GM
volume, predominantly within the PFC. Additionally we used multiple
regression analyses to assess the speciﬁc relation between a certain
substance and GM volume, both with and without including the use of
other substances as a covariate in the model.
2. Materials and methods
2.1. Participants
Structural MRI scans of 256 participants were available, collected as
part of three published studies (Jansen et al., 2015; Kaag et al., 2016a;
Schulte et al., 2017) between January 2012 and December 2015. In
short, all participants included in the current analyses were males (aged
18–60), recruited through local advertisement in the greater Am-
sterdam area, The Netherlands. Study speciﬁc in- and exclusion were as
followed: In the study by Schulte et al. (2017) inclusion criteria were:
male; 18–55 years old; smoking at least 15 cigarettes per day; a desire
to quit smoking; a Fagerström Test Nicotine Dependence (FTND;
Heatherton et al., 1991) score of at least 3, indicating at least a low
degree of smoking dependence, and an Alcohol Use Disorder Identiﬁ-
cation (AUDIT) score lower than 13, indicating the absence of heavy
alcohol use and/or an alcohol use disorder. In the study by Kaag et al.
(2016a,b) inclusion criteria were: male; 18–50 years old; non-treatment
seeking; and snorting cocaine at least once per week in the last 6
months. Healthy controls were also excluded if they reported a history
of substance abuse or dependence including tobacco use, and in case of
any psychotropic medication use. In the study by Jansen et al. (2015),
alcohol-dependent patients (DSM-IV diagnosis) were recruited from
addiction treatment centers in Amsterdam and had to be abstinent from
alcohol for at least three weeks. Healthy controls were recruited
through internet and social media and excluded if they met any DSM-IV
criteria for psychiatric disorders. Control participants had to remain
abstinent from alcohol for 24 h only. While females were also included
in this speciﬁc study, they were not included in the current analyses
because none of the other studies included female smokers or cocaine
users (Note: in the ﬁnal analyses only, the male control participants are
included, but none of the alcohol-dependent patients). Alcohol, to-
bacco, cocaine and cannabis use was quantiﬁed using the Timeline
Follow-back on 1 or 6 months before the study (Sobell and Sobell,
1992) or the Composite International Diagnostic Interview (Robins
et al., 1988), in all three studies. Similarly, substance use, AUDIT-scores
and FTND-scores was measured in all three studies, but DSM-IV diag-
nosis of psychiatric disorders, including substance use disorder, were
only measured in the studies by Jansen et al. (2015) and Kaag et al.
(2016a,b). Motivation to change substance use was measured in sub-
stance-users only, using the motivation to change questionnaire (RCQ:
Heather et al., 1991). For the current study, all these participants were
combined and categorized again based on the number of substances
used. The studies were approved by the local Medical Ethics Committee
of the Academic Medical Center of the University of Amsterdam or the
Ethics Committee of the University of Amsterdam. All participants
signed the informed consent form, consistent with the declaration of
Helsinki, before participating in the study.
2.2. Participant selection and subgroup categorization
Based on self-report measures of alcohol, tobacco, cocaine and
cannabis use, all participants were classiﬁed as heavy drinker (> 21
units of alcohol per week), light drinker (≤21 units of alcohol per
week) or non-drinker (0 units of alcohol per week); smoker (> 1 ci-
garette per day) or non-smoker (0 cigarettes per day); cocaine user
(≥1 g of cocaine per week) or non-cocaine user (0 g of cocaine per
week) and cannabis user (≥1 joint per week) or non-cannabis user (0
joints per week). Cut-oﬀ values are in accordance with previous studies
(Buckner and Schmidt, 2008; Griﬃths, 1996; Kaag et al., 2016a;
Medina et al., 2007; Roebuck et al., 2004). The classiﬁcation resulted in
(3 alcohol groups× 2 smoking groups× 2 cocaine groups× 2 can-
nabis groups=) 24 potential subgroups of participants that varied from
using either a single or no substance, to using any combination of al-
cohol, tobacco, cocaine and cannabis.
Because of one or more missing self-reported measures, 46
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participants were excluded. In line with our previous research, we se-
lected subgroups that increased in the number of substances used and
had a minimal sample size of n= 10 (Kaag et al., 2016b). Doing so we
ended up with 6 diﬀerent subgroups that increased in the number of
substance used: Non-alcohol or drug users (n=15), light alcohol
drinkers (n= 89), light drinkers who smoke tobacco (n= 27), light
drinkers who smoke tobacco and use cocaine (n= 13), heavy drinkers
who smoke tobacco and use cocaine (n= 10) and heavy drinkers who
smoke tobacco and cannabis and use cocaine (n= 15). All other par-
ticipants and subgroups were not included in the analyses (Table 1).
2.3. Magnetic resonance imaging acquisition and processing
All structural images from the three diﬀerent studies were acquired
on the same 3T whole body MRI scanner (Phillips Achieva), with a 32
channel SENSE head coil. Three-dimensional T1-weighted images were
acquired with the following parameters: repetition time
(TR)= 8.24ms, echo time (TE)= 3.79ms, ﬂip angle= 8°, slice thick-
ness= 1mm, scan resolution=240mm×240mm, ﬁeld-of-view
(FOV) (anterior-posterior/feet–head/right–left) = 240/240/220mm,
and voxel size= 1mm3.
Pre-processing was performed using the default settings of the
CAT12 toolbox (http://dbm.neuro.uni-jena.de/vbm.html) within
SPM12 (http://www.ﬁl.ion.ucl.ac.uk/spm) running on MATLAB
R2016a (Mathworks Inc., Natick, MA, USA). All T1- weighted images
were corrected for bias and ﬁeld inhomogeneities, then spatially nor-
malized using the DARTEL algorithm (Ashburner, 2007) and segmented
into gray matter (GM), white matter (WM) and cerebrospinal ﬂuid
(CSF) (Ashburner, 2007). The segmentation process was further ex-
tended by accounting for partial volume eﬀects (Tohka et al., 2004).
Subsequently, data was de-noised by applying a spatial-adaptive non-
local means ﬁlter and by using adaptive maximum a posteriori esti-
mations, which account for partial volume eﬀects, and by applying a
hidden Markov random ﬁeld model, as implemented in VBM8
(Rajapakse et al., 1997). For exclusion of artifacts on the gray–white-
matter border (i.e., incorrect voxel classiﬁcation), we applied an in-
ternal gray matter threshold of 0.2. After pre-processing (in addition to
visual checks for artifacts), all scans passed through an automated
quality check protocol. Finally, the scans were smoothed with a
smoothing kernel of 8mm (FWHM).
2.4. Statistical analysis
For all participants, we calculated the number of cigarettes per day,
the number of standard units of alcohol per week, the number of joints
per week and the total grams of cocaine use per week. All participants
were categorized based on the self-reported number of substances used,
ranging from no-alcohol or drug use; light alcohol use light alcohol
use+ tobacco use; light alcohol use+ tobacco use+ cocaine use;
heavy alcohol use+ tobacco use+ cocaine use; heavy alcohol
use+ tobacco use+ cocaine use+ cannabis use. Chi-square tests were
used to test whether the four tobacco using groups were indeed mat-
ched on tobacco use; whether the three cocaine using groups were
matched on cocaine use; whether the three light drinking groups were
matched on alcohol use; and whether the two heavy drinking groups
were matched on alcohol intake.
To assess the combined eﬀect of substances used in GM volume, a
whole brain voxel-wise regression analysis was performed in SPM12,
with the number of substances used as a regressor of interest and age
and intracranial volume (ICV) as covariates. All regressors were cen-
tered around the mean.
To assess the eﬀects of substances on GM volume, without con-
trolling for the use of other substances, four diﬀerent, whole-brain
voxelwise, regression analyses were performed on each substance se-
parately, with only age and ICV as covariates.
To assess the speciﬁc eﬀects of a certain substance on the GM vo-
lume, controlling for the use of other substances, a whole brain vox-
elwise multiple regression analyses were performed with the amount of
alcohol, tobacco, cocaine, and cannabis used as regressors of interest
and age and ICV as covariates. Results were statistically thresholded at
the cluster level (p < 0.05, FWE corrected) with a cluster-deﬁning
threshold of P < 0.001, uncorrected.
3. Results
3.1. Substance use characteristics
Of all participants included in the analyses, 110 were originally
scanned as part of the study by Kaag et al. (2016a), of which 38 were
included as regular cocaine users and 72 as non-drug using controls. A
total of 39 participants were originally scanned as part of the study by
Schulte et al. (2017), of whom 24 were included as smokers and 15 as
non-smoking controls. A total of 19 participants were originally
scanned as part of the study by Jansen et al. (2015), all of which were
included as controls. For more details see Table 2. Importantly, all
participants were either non-drug or alcohol users, or non-abstinent
substance users.
Subgroups did not diﬀer in their motivation to change substance use
(F1,77= 0.77, p= 0.58). Age and self-reported substance use were not-
normally distributed across groups; thus non-parametric tests were used
to test group diﬀerences. There was no signiﬁcant diﬀerence between
groups in age (χ2= 8.7, p= 0.12). Chi-square tests demonstrated that
Table 1
Classiﬁcation table of all participants, based on the number of substances used.
The numbers represent the number of participants in that category.
The groups in black are included in the analyses, the groups in gray are excluded from the analyses.
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there was a signiﬁcant diﬀerence in alcohol intake between the three
light-drinking groups (χ2= 18.72, p < 0.001). Follow-up tests re-
vealed that light drinkers who use tobacco and cocaine drank sig-
niﬁcantly more compared to light drinkers who use tobacco but no
cocaine (χ2= 7.77, p=0.005) while this latter group drank sig-
niﬁcantly more compared to light drinkers who did not use tobacco or
cocaine (χ2= 4.07, p=0.04). The heavy drinking groups and smoking
groups were well-matched on alcohol (χ2= 0.89, p=0.35) and the
tobacco use (χ2= 5.64, p=0.13), respectively.
The only measures of substance use severity that was taken in all
three studies were smoking severity (FTND) and alcohol use severity
(AUDIT). Chi-square tests demonstrated that smoking severity was si-
milar in all four smoking groups (χ2= 2.88, p=0.41). However, si-
milar to alcohol intake, the light drinking groups diﬀered signiﬁcantly
in alcohol-use severity (χ2= 22.82, p < 0.001), as light drinkers who
use tobacco and cocaine reported a signiﬁcantly higher AUDIT-score
compared to light drinkers who use tobacco but no cocaine
(χ2= 15.91, p < 0.001) and light drinkers who do not use tobacco or
cocaine (χ2= 21.29, p < 0.001) whereas these latter two groups did
not diﬀer in terms of alcohol use severity. These results suggest that,
despite our eﬀorts, the light drinking groups were not perfectly mat-
ched on alcohol intake or alcohol use severity.
It should be noted that despite the fact that light drinkers who also
used tobacco and cocaine reported a ‘low to moderate’ level of alcohol
use (equal or less than 21 units per week), a substantial proportion of
these participants met DSMIV criteria for lifetime alcohol abuse (84%)
or dependence (23%). Similarly, a relatively large proportion of the
cocaine users who did not report the use of cannabis in the past 6
months met DSMIV criteria for lifetime cannabis abuse (45%) or de-
pendence (18%) (see Table 2). Unfortunately, DSMIV diagnosis of
substance use disorder was not assessed in all three studies; hence, the
DSMIV diagnoses were absent for 7% of the non-substance users and
light drinkers, as well as for 89% of the light drinkers who used tobacco,
making statistical comparisons on this variable impossible.
3.2. The relation between GM volume and the use of alcohol, tobacco,
cocaine, and cannabis
To assess the combined eﬀect of substances used on GM volume,
multiple regression analysis was performed with the number of sub-
stances used as a regressor of interest and age and ICV as covariates.
This analysis revealed a signiﬁcant negative relation between the
number of substances used and gray matter volume of the dmPFC and
vmPFC (Fig. 1 in red; Table 3).
To assess the speciﬁc eﬀects of substances used on GM volume,
when controlling for the use of the other substances, multiple regression
analysis was performed with the amount of alcohol, tobacco, cocaine,
and cannabis used as a regressor of interest and age and ICV as re-
gressors of no-interest. This analysis revealed a negative correlation
between monthly cocaine use and GM volume of the vlPFC (including
the orbital frontal cortex) and right insula (Fig. 1 in blue; Table 4)
whereas daily tobacco use was negatively correlated with GM volume
of the thalami (Fig. 1 in green, Table 4). Importantly, GM volume re-
ductions related to the number of substances used do not overlap with
the GM regions that showed a dose-response relationship with cocaine
or tobacco use. That is, for none of these substances we demonstrated a
negative dose-response relationship with dmPFC or vmPFC volume.
There were no positive or negative associations between gray matter
volume and monthly cannabis use or weekly alcohol use.
To assess the eﬀects of substances on GM volume, uncorrected for
the use of other substances, four whole brains, FWE-cluster corrected,
regression analyses were performed with the amount of alcohol or to-
bacco or cocaine or cannabis use as a regressor of interest, and age and
ICV as regressors of no-interest. These analyses demonstrated that there
Table 2
Participant characteristics of the ﬁnal sample included in the analyses.
aAll participants were non-smokers, so the FTND was not assessed
bLifetime substance use or dependence was assessed using the DSM-IV criteria. This was not assessed in Schulte et al., (in preparation).
Cells in light gray indicate that groups were supposed to be matched on that speciﬁc variable, but in fact diﬀered.
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was no signiﬁcant dose-response relation between weekly cannabis use
and GM volume. However, alcohol, tobacco and cocaine all showed a
negative dose-response relation to dmPFC volume, the same region
where the volume was negatively related to the total number of sub-
stances used (Fig. 2, Table 5) In addition, for cocaine there was a ne-
gative dose-response relation with GM volume of the vmPFC and insula,
whereas daily tobacco use was also negatively correlated to GM of the
thalamus.
4. Discussion
The study aimed to investigate the relation between gray matter
volume and the use of alcohol, tobacco, cocaine, and cannabis in male
(poly)substance users. By categorizing participants on the number of
substances used, ranging from nothing to the combination of alcohol,
tobacco, cocaine, and cannabis, we demonstrated a negative relation-
ship between the number of substances used and volume of the dmPFC
and vmPFC. While previous studies have demonstrated smaller mPFC
volume in cocaine users (Ersche et al., 2011; Fein et al., 2002), cannabis
users (Lopez-Larson et al., 2011), heavy alcohol users (Xiao et al., 2015;
Yang et al., 2016) and smokers (Zhong et al., 2016), the current study
suggest that volume of the mPFC is in reality not (dose-dependently)
related to these speciﬁc substances, but rather to the number of sub-
stance used. This is in line with our previous study that demonstrated
that the number of substances used was negatively related to white
matter integrity, speciﬁcally within the prefrontal cortex (Kaag et al.,
2016b). In general, the mPFC has been implicated in a wide range of
cognitive processes and behavior, including cognitive control, emotion
regulation, decision making and goal-directed behavior (Bechara, 2005;
Etkin et al., 2011; Ridderinkhof, 2004). However, the dorsal part
(dmPFC) has been mainly implicated in the expression of (drug) con-
ditioned behavior, whereas the ventral part (vmPFC) has been mainly
implicated in the inhibition of (drug) conditioned behavior (Gourley
and Taylor, 2016; Moorman et al., 2015). Hence the negative relation
between the number of substances used and GM volume of the dmPFC
and vmPFC may underlie an imbalance between this ‘Go vs. Stop’
system, resulting in impaired control of drug-taking behavior
(Moorman et al., 2015). Interestingly, smaller dmPFC volumes have
also associated with poorer treatment outcome in alcohol-dependent
patients (Rando et al., 2011). Therefore, smaller dmPFC volumes in
polysubstance users may be related to the often observed relative
treatment-resistance within this population (Dutra et al., 2008).
We also demonstrated a speciﬁc relation (controlling for the use of
other substances) between tobacco use and thalamic volumes, as well as
a speciﬁc relation between cocaine use and volume of the vlPFC and
insula. This is not the ﬁrst study to demonstrate a negative relation
between smoking and thalamus volume (Hanlon et al., 2016; Liao et al.,
2012; Peng et al., 2015; Yu et al., 2017). The thalamus is critically
involved in the motivation, emotional drive, and planning of goal-di-
rected behavior (Haber and Calzavara, 2009). Moreover, the thalamus
has a very high density of acetylcholine (nicotine) receptors, making
this region the primary target for nicotine binding (Wonnacott, 1997;
Zubieta et al., 2001). Because of this, the thalamus may be speciﬁcally
vulnerable for the neurotoxic eﬀects of nicotine (and not other sub-
stances) and/or may play a critical role in the development and per-
sistence of nicotine dependence (Hanlon et al., 2016).
The speciﬁc, negative (dose-dependent) relation between cocaine
use and volume of the vlPFC is also in line with previous studies
(Franklin et al., 2002; Matochik et al., 2003; Rando et al., 2013). The
vlPFC (including the OFC) has been suggested to be involved in higher-
order emotional control (Shiba et al., 2016) and automatic response
tendencies and response inhibition (Goldstein and Volkow, 2011). This
could be related to impaired decision making (Fernandez-Serrano et al.,
2011) and (neural) hyperresponsiveness to negative emotional stimuli
(Crunelle et al., 2015; Kaag et al., 2016a) in regular cocaine users.
In line with another study (Bullock et al., 2017) we did not ﬁnd a
Fig. 1. Regional alterations in gray matter volume related to
the number of substances used do not overlap with the volume
of gray matter regions that show a substance dose-response
relationship. The number of substances used is negatively
correlated to gray matter volume in the dorsomedial pre-
frontal cortex and the orbital medial prefrontal cortex. These
regions do not overlap with the regions that display a dose-
response relationship with cocaine, tobacco and cannabis.
That is, cocaine use is negatively related to regions in the more
lateral regions of the orbital frontal cortex, and tobacco use is
negatively correlated to volume of the thalamus. (For inter-
pretation of the references to colour in the text, the reader is
referred to the web version of this article.)
Table 3
The combined eﬀect of substance use on gray matter volume.
Cluster size Cluster Voxel Peak voxel Voxel region (AAL atlas/broadmann area)
# voxels P-value z-value MNI-coordinates
# of substances used: negative correlation 4065 <0.001 4,77 6 15 42 R midcingulate cortex
4,6 −27 40 32 L middle frontal cortex
4,51 0 24 38 L medial frontal cortex
4,46 −16 44 26 L superior frontal cortex
4,44 −2 8 52 L supplementary motor area/BA 32
3,75 −6 28 33 L midcingulate cortex/BA 9
3,66 12 0 48 R supplementary motor area
3,52 −6 38 26 L anterior cingulate cortex/BA32
2315 <0.001 4,72 −3 45 −24 L rectus/BA 11
4,14 9 50 −22 R superior frontal cortex, orbital part
3,85 9 28 −21 R rectus
3,38 10 12 −20 R olfactory cortex
# of substances used: positive correlation No signiﬁcant positive correlations
All results were p < 0.05, cluster level family-wise error corrected with an initial height threshold of p=0.001 uncorrected.
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Table 4
The speciﬁc eﬀect substance use on gray matter volume, controlled for the use of other substances
Cluster size Cluster Voxel Peak voxel Voxel region (AAL atlas/broadmann area)
# voxels P-value z-value MNI-coordinates
Monthly cocaine use: Negative correlation 2426 <0.001 4,34 −30 48 −6 L medial orbital frontal cortex
4,25 −14 57 −2 Frontal_Sup_Medial_L
3,81 −21 51 −9 Frontal_Sup_Orb_L
3,75 −38 50 4 Frontal_Mid_L/BA 10
3,59 −45 56 9 Frontal_Mid_L/BA 46
3,49 −51 34 −12 Frontal_Inf_Orb_L
883 0.003 3,84 57 30 −9 Frontal_Inf_Orb_R/BA47
3,76 34 51 0 Frontal_Mid_R
3,48 46 21 −4 Insula_R
Monthly cocaine use: positive correlation No signiﬁcant positive correlations
Daily cigarette use: negative correlation 7686 <0.001 5,74 10 −18 14 Thalamus_R
5,42 20 −4 0 Pallidum_R
5,39 10 −2 0 Thalamus_L
Daily cigarette use: positive correlation No signiﬁcant positive correlations
Monthly cannabis use No signiﬁcant positive or negative correlations
Weekly alcohol use No signiﬁcant positive or negative correlations
All results were p < 0.05, cluster level family-wise error corrected with an initial height threshold of p=0.001 uncorrected.
Fig. 2. The relation between GM volume and alcohol, tobacco,
tobacco and alcohol use, uncorrected for the use of other
substances. Alcohol, cocaine and tobacco use were all nega-
tively related to dorsomedial prefrontal cortex volume, the
same region that showed a negative relation with the number
of substances used. Additionally, cocaine use was negatively
related to ventromedial prefrontal cortex volume and tobacco
use was negatively related to volume of the thalami.
Table 5
The general eﬀect substance use on gray matter volume, uncontrolled for the use of other substances.
Cluster size Cluster Voxel Peak voxel Voxel region (AAL atlas/broadmann area)
# voxels P-value z-value MNI-coordinates
Monthly cocaine use: Negative correlation 5975 <0.001 5,27 −34 44 32 Frontal_Mid_L/BA9
4,81 −4 32 30 Cingulum_Ant_L/BA32
4,45 −42 44 28 Frontal_Mid_L
4,26 −14 57 −2 Frontal_Med_Orb_L
4,14 −2 8 54 Supp_Motor_Area_L/BA6
4,09 −15 34 27 Frontal_Sup_Medial_L/B32
4,07 −2 4 44 Cingulum_Mid_L
3569 <0.001 4,62 9 52 −22 Frontal_Sup_Orb_R
4,42 −14 32 −16 Rectus_L/BA47
4,28 3 60 −21 Rectus_R/BA11
3,86 16 60 −2 Frontal_Sup_Medial_R
3,43 26 20 −18 Insula_R
3,29 10 12 −20 Olfactory_R
1990 <0.001 3,39 27 40 −14 Frontal_Mid_Orb_R/BA11
Monthly cocaine use: positive correlation No signiﬁcant positive correlations
Weekly alcohol use: negative correlation 1006 0.002 4,39 9 9 44 Cingulum_Mid_R
3,69 0 22 38 Frontal_Sup_Medial_L
3,42 −4 28 32 Cingulum_Mid_L
3,37 0 8 51 Supp_Motor_Area_L
Weekly alcohol use: positive correlation No signiﬁcant positive correlations
Monthly cannabis use: No signiﬁcant negative or positive correlations
Daily cigarette use: negative correlation 4816 <0.001 4,96 −9 −20 9 Thalamus_L
4,92 15 −2 4 Medial Dorsal Nucleus
4,69 6 −12 8 Thalamus_R
3,62 −20 −8 −3 Pallidum_L
Daily cigarette use: positive correlation No signiﬁcant positive correlations
All results were p < 0.05, cluster level family-wise error corrected with an initial height threshold of p=0.001 uncorrected.
A.M. Kaag et al. Drug and Alcohol Dependence 187 (2018) 186–194
191
speciﬁc relation between alcohol use and mPFC volume, after control-
ling for the use of other substance. This may come as a surprise as mPFC
volume reductions have consistently been demonstrated in alcohol-
abusing populations (Bühler and Mann, 2011; Yang et al., 2016), and
could indicate that poly-substance use may have played a role in these
ﬁndings too (which should be investigated further in future studies).
However, because many previous studies did not account for the use
of other substances, it may very well be that the negative relation be-
tween alcohol use and mPFC volume, at least partly, reﬂects a negative
relation between the mPFC volume and the number of other substances
used. Indeed, it has been suggested that alcohol use is more frequent, in
polydrug users (Barrett et al., 2006). Finally, we did not demonstrate a
negative relation between cannabis use and GM volume. While, the
current ﬁnding does replicate some other negative studies (Cousijn
et al., 2012; Haller et al., 2013), we may have had too little statistical
power to demonstrate a signiﬁcant relation between cannabis use and
cortical GM volume (as only 6% of the current sample actually smoked
cannabis).
Because of the cross-sectional nature of the current study, we cannot
draw any conclusions on the causal relation between [1] the smaller
mPFC volume and the number of substances used, [2] the smaller
thalami volume and tobacco use and [3] the smaller vlPFC volume and
cocaine use. Nicotine, alcohol, cocaine, and cannabis all have diﬀerent
mechanisms of action (Pierce and Kumaresan, 2006): cocaine directly
acts on the dopamine transporter in the ventral tegmental area (VTA),
alcohol positively modulates GABAergic interneurons in the VTA,
cannabinoids inhibit GABA release from the VTA; nicotine activates
acetylcholine receptors, increase glutamate and decreases GABA
transmission in the VTA. Because of these diﬀerent (sometimes oppo-
site) working mechanisms, it is unlikely that the negative relation be-
tween mPFC volume and the number of substances used is the result of
the neurotoxic eﬀects of these substances on the brain. Therefore,
smaller mPFC volumes may predispose an individual to develop a
(poly) substance use disorder, rather than being a consequence of (poly)
substance use. This hypothesis is supported by a previous study that
demonstrated that smaller dmPFC volumes predict escalating substance
use (Becker et al., 2015). Alternatively, the smaller dmPFC volume may
be related to substance use severity in general. Moreover, the current
study provides important evidence that thalamic pathology is speciﬁ-
cally associated with tobacco use (and not another substance of abuse),
whereas vlPFC pathology is speciﬁcally related to cocaine use (and not
another substance of abuse), which could reﬂect speciﬁc neurotoxic
eﬀects of these substances. Importantly, these hypothesized causal re-
lationships between substance use and mPFC, vlPFC, and thalami vo-
lume should be conﬁrmed using animal studies or longitudinal human
studies.
In the current study, we combined VBM data from three diﬀerent
studies, which resulted in the inclusion of 169 substance using and non-
substance using males. This large population enabled us to investigate
the eﬀect of polysubstance use in a general population sample. Because
we assessed the relation between the number of substances used and
GM volume in addition to applying multiple regression analyses, we
demonstrated structural alterations in the mPFC that would otherwise
have been missed. These ﬁndings contribute to the existing literature
because currently very little is known about the relation between gray
matter volume and polysubstance use, despite the high prevalence of
polysubstance use and the severity of mental health issues associated
with polysubstance use (Connor et al., 2014; Dutra et al., 2008).
Moreover, our study provides an alternative and additional method to
address the issue of polysubstance use among substance dependent
populations, which could be applied in future studies as well. However,
the current (naturalistic) study also has some limitations: First, because
we wanted to include subgroups that increased in the number of sub-
stance used, by adding the use of one extra substance in each subgroup,
and because some other subgroups were considered too small to be
included in the analyses, some potentially important groups, were
excluded. Future studies should be performed to establish whether the
relation between dmPFC volume and the number of substance used,
also holds for other combination of substances. Another result of our
categorization method is that not all ‘groups’ had an equal sample size
and some were relatively small compared to the other groups; however,
we used our categorization to label participants with the number of
substance used, that was subsequently used a regressor in the analyses.
Doing so, the unequal sample sizes do not yield a statistical issue.
Moreover, while we aimed to end up with subgroups of substances users
that diﬀered from each other only in the number of substances used,
alcohol use in smokers was signiﬁcantly higher compared to non-
smokers, and alcohol use in cocaine users was signiﬁcantly higher
compared to non-cocaine users. Therefore, we cannot exclude the
possibility that the negative relation between the number of substances
used and the mPFC volume is mainly driven by alcohol use. Through
collapsing even more datasets, we may be able to address these issues in
future studies. It should be noted that, in the current study, we used a
cut-oﬀ of 21 units 10 g of alcohol per week (total of 210 g of alcohol).
While this is in line with the current guidelines used in the Netherlands
to deﬁne excessive drinking in men (Netherlands Institute of Mental
Health and Addiction, 2016), it is slightly higher than the novel
guidelines by the NIAAA that deﬁnes and a moderate alcohol use as a
maximum of 14 units of alcohol per week containing 14 g of alcohol per
unit (a total of 196 g of alcohol per week). Note that the current
guidelines in the Netherlands were also adjusted to: best not drink, and
when you drink maximally one glass per day.
Another limitation of this study is that we did not address the spe-
ciﬁc interactions between the diﬀerent substances. While the interac-
tion between diﬀerent substances is a very important issue (Althobaiti
and Sari, 2016; Jutkiewicz et al., 2008; Lopes et al., 2012; Valjent et al.,
2002; Wheeler et al., 2008) testing these four-way interactions would
have been highly complex in the current sample. In addition, we have
focused our research on the relation between the number of substances
used and brain volume, thereby seemingly ignoring a lot of other im-
portant factors involved in the polysubstance use, including the age of
onset and whether the substances are used simultaneously. Un-
fortunately, we did not have this data because of the exploratory nature
of the study and could therefore not assess these important questions. In
this study only, males were included because this leads to more
homogenous groups and therefore strengthens the results of the study.
Moreover, while the prevalence of smoking in the Netherlands is rela-
tively similar among males and females (22% and 17% respectively),
the prevalence of cocaine use is three times as high among males than
females (Netherlands Institute of Mental Health and Addiction, 2016).
It may, therefore, be more relevant to assess the relation between
substance use and gray matter volume in males ﬁrst. It is important to
note, however, that the few studies that have included both males and
females, provided limited evidence for relevant sex diﬀerences in gray
matter volume in alcohol use disorder (Demirakca et al., 2011a; Thayer
et al., 2016) and cocaine use disorder (Ide et al., 2014). Nonetheless, it
remains to be investigated how the current ﬁndings translate to a fe-
male population. Another potential concern of this study could be that
the diﬀerence in- and exclusion criteria of the studies, resulted in po-
pulations that are too diﬀerent to collapse in one analysis. However,
due to our categorization none of the abstinent alcohol-dependent pa-
tients originally included as part of the study by Jansen et al. (2015),
were included in the ﬁnal analyses. Therefore, only active users of co-
caine (included as part of the study by Kaag et al., 2016a), cigarettes
(included as part of the study by Schulte et al., 2017), and matched non-
drug using controls, were included in our ﬁnal analyses. A potentially
relevant diﬀerence between these populations could be that the cigar-
ette smokers were included in an intervention study and therefore
motivated to change their smoking behavior, whereas the cocaine users
were not speciﬁcally included based on their motivation to change their
cocaine use behavior. Based on the total score of the RCQ, it became
evident, however, that there were no signiﬁcant diﬀerences between
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smokers and cocaine users in their motivation to change smoking and
cocaine use, respectively or between the subgroups as included in the
analyses. Hence, we are conﬁdent that potential diﬀerences between
the diﬀerent study populations with respect to motivation to change,
did not aﬀect our results.
While we acknowledge these limitations that are related to the
naturalistic design used in the current study, we strongly feel that this
study does provide relevant and important information that contributes
to our neurobiological understanding of polysubstance use.
In sum, we demonstrated a negative eﬀect of the number of sub-
stances used on the GM vmPFC and dmPFC volumes as well as a sub-
stance non-speciﬁc dose-response relationship between substance use
and dmPFC volume. In addition, we showed a substance-speciﬁc ne-
gative association between tobacco use and thalamic GM volume as
well as a substance-speciﬁc negative association between cocaine use
and vlPFC GM volume. These results suggest that a smaller GM mPFC
volume either reﬂects substance use severity or may predispose to
(poly) substance use whereas smaller GM thalamic volume and smaller
GM vlPFC volume are more likely to result from the neurotoxic eﬀects
of tobacco and cocaine on the brain. However, only animal or long-
itudinal studies can establish this causal relationship. Because the
dmPFC, vmPFC, vlPFC and thalamus have all been implicated in dif-
ferent neurocognitive processes (Bechara, 2005; Etkin et al., 2011;
Goldstein and Volkow, 2011; Gourley and Taylor, 2016; Haber and
Calzavara, 2009; Moorman et al., 2015; Ridderinkhof, 2004; Shiba
et al., 2016), the combined and speciﬁc eﬀects of alcohol tobacco, co-
caine and cannabis on GM volume may reﬂect diﬀerential cognitive
deﬁcits among substance users.
Role of funding source
This study was made possible by a grant provided by ZonMW (grant
number 91211002).
Contributions
AMK collected a part of the data, analyzed all the data and perpe-
trated the ﬁrst draft of the manuscript. MHJS and JMJ collected parts of
the data. GvW assisted with the data analyses. GvW, JH, WvdB, RWW,
LS, AEG and LR actively participated in writing and revising the
manuscript for publication. All authors have read and approved the
ﬁnal manuscript.
Conﬂicts of interest
No conﬂict declared.
References
Alia-Klein, N., Parvaz, M.A., Woicik, P.A., Konova, A.B., Maloney, T., Shumay, E., Wang,
R., Telang, F., Biegon, A., Wang, G.J., Fowler, J.S., Tomasi, D., Volkow, N.D.,
Goldstein, R.Z., 2011. Gene x disease interaction on orbitofrontal gray matter in
cocaine addiction. Arch. Gen. Psychiatry 68, 283–294.
Althobaiti, Y.S., Sari, Y., 2016. Alcohol interactions with psychostimulants: an overview
of animal and human studies. J. Addict. Res. Ther. 7, 338–348.
Ashburner, J., 2007. A fast diﬀeomorphic image registration algorithm. Neuroimage 38,
95–113.
Bühler, M., Mann, K., 2011. Alcohol and the human brain: a systematic review of diﬀerent
neuroimaging methods. Alcohol. Clin. Exp. Res. 35, 1771–1793.
Barrós-Loscertales, A., Garavan, H., Bustamante, J.C., Ventura-Campos, N., Llopis, J.J.,
Belloch, V., Parcet, M.A., Avila, C., 2011. Reduced striatal volume in cocaine-de-
pendent patients. Neuroimage 56, 1021–1026.
Barrett, S.P., Darredeau, C., Pihl, R.O., 2006. Patterns of simultaneous polysubstance use
in drug using university students. Hum. Psychopharmacol. 21, 255–263.
Bechara, A., 2005. Decision making, impulse control and loss of willpower to resist drugs:
a neurocognitive perspective. Nat. Neurosci. 8, 1458–1463.
Becker, B., Wagner, D., Koester, P., Tittgemeyer, M., Mercer-Chalmers-Bender, K.,
Hurlemann, R., Zhang, J., Gouzoulis-Mayfrank, E., Kendrick, K.M., Daumann, J.,
2015. Smaller amygdala and medial prefrontal cortex predict escalating stimulant
use. Brain 138, 2074–2086.
Buckner, J.D., Schmidt, N.B., 2008. Marijuana eﬀect expectancies: relations to social
anxiety and marijuana use problems. Addict. Behav. 33, 1477–1483.
Bullock, K., Cservenka, A., Ray, L.A., 2017. Severity of alcohol dependence is negatively
related to hypothalamic and prefrontal cortical gray matter density in heavy drinking
smokers. Am. J. Drug Alcohol Abuse 43, 281–290.
Connor, J.P., Gullo, M.J., White, A., Kelly, A.B., 2014. Polysubstance use: diagnostic
challenges, patterns of use and health. Curr. Opin. Psychiatry 27, 269–275.
Cousijn, J., Wiers, R.W., Ridderinkhof, K.R., Van den Brink, W., Veltman, D.J., Goudriaan,
A.E., 2012. Grey matter alterations associated with cannabis use: results of a VBM
study in heavy cannabis users and healthy controls. Neuroimage 59, 3845–3851.
Crunelle, C.L., Kaag, A.M., van Wingen, G., van den Munkhof, H.E., Homberg, J.R.,
Reneman, L., van den Brink, W., 2014. Reduced frontal brain volume in non-treat-
ment-seeking cocaine-dependent individuals: exploring the role of impulsivity, de-
pression, and smoking. Front. Hum. Neurosci. 8, 7.
Crunelle, C.L., Kaag, A.M., Van den Munkhof, H.E., Reneman, L., Homberg, J.R., Sabbe,
B., Van den Brink, W., Van Wingen, G., 2015. Dysfunctional amygdala activation and
connectivity with the prefrontal cortex in current cocaine users. Hum. Brain Mapp.
36, 4222–4230.
Demirakca, T., Ende, G., Kämmerer, N., Welzel-Marquez, H., Hermann, D., Heinz, A.,
Mann, K., 2011a. Eﬀects of alcoholism and continued abstinence on brain volumes in
both genders. Alcohol. Clin. Exp. Res. 35, 1678–1685.
Demirakca, T., Sartorius, A., Ende, G., Meyer, N., Welzel, H., Skopp, G., Mann, K.,
Hermann, D., 2011b. Diminished gray matter in the hippocampus of cannabis users:
possible protective eﬀects of cannabidiol. Drug Alcohol Depend. 114, 242–245.
Dutra, L., Stathopoulou, G., Basden, S.L., Leyro, T.M., Powers, M.B., Otto, M.W., 2008. A
meta-analytic review of psychosocial interventions for substance use disorders. Am.
J. Psychiatry 165, 179–187. http://dx.doi.org/10.1176/appi.ajp.2007.06111851.
Ersche, K.D., Barnes, A., Simon Jones, P., Morein-Zamir, S., Robbins, T.W., Bullmore, E.T.,
2011. Abnormal structure of frontostriatal brain systems is associated with aspects of
impulsivity and compulsivity in cocaine dependence. Brain 134, 2013–2024. http://
dx.doi.org/10.1093/brain/awr138.
Etkin, A., Egner, T., Kalisch, R., 2011. Emotional processing in anterior cingulate and
medial prefrontal cortex. Trends Cogn. Sci. 15, 85–93. http://dx.doi.org/10.1016/j.
tics.2010.11.004.
European Monitoring Centre for Drugs and Drug Addiction, 2009. Polydrug Use: Patterns
and Responses. http://www.emcdda.europa.eu/publications/selected-issues/
polydrug-use-patterns-and-responses_en. (Accessed 9 April 2018).
Fein, G., Di Sclafani, V., Meyerhoﬀ, D.J., 2002. Prefrontal cortical volume reduction as-
sociated with frontal cortex function deﬁcit in 6-week abstinent crack-cocaine de-
pendent men. Drug Alcohol Depend. 68, 87–93.
Fernandez-Serrano, M.J., Perez-Garcia, M., Verdejo-Garcia, A., 2011. What are the spe-
ciﬁc vs. generalized eﬀects of drugs of abuse on neuropsychological performance?
Neurosci. Biobehav. Rev. 35, 377–406.
Franklin, T.R., Acton, P.D., Maldjian, J.A., Gray, J.D., Croft, J.R., Dackis, C.A., O’Brien,
C.P., Childress, A.R., 2002. Decreased gray matter concentration in the insular, or-
bitofrontal, cingulate, and temporal cortices of cocaine patients. Biol. Psychiatry 51,
134–142.
Goldstein, R.Z., Volkow, N.D., 2011. Dysfunction of the prefrontal cortex in addiction:
neuroimaging ﬁndings and clinical implications. Nat. Rev. Neurosci. 12, 652–669.
Gourley, S.L., Taylor, J.R., 2016. Going and stopping: dichotomies in behavioral control
by the prefrontal cortex. Nat. Commun. 19, 1–11.
Griﬃths, E., 1996. Sensible drinking: doctors should stick with the independent medical
advice. Br. Med. J. 312, 1.
Haber, S.N., Calzavara, R., 2009. The cortico-basal ganglia integrative network: the role
of the thalamus. Brain Res. Bull. 78, 69–74.
Haller, S., Curtis, L., Badan, M., Bessero, S., Albom, M., Chantraine, F., Alimenti, A.,
Lovblad, K.O., Giannakopoulos, P., Merlo, M., 2013. Combined grey matter VBM and
white matter TBSS analysis in young ﬁrst episode psychosis patients with and without
cannabis consumption. Brain Topogr. 26, 641–647.
Hanlon, C.A., Dufault, D.L., Wesley, M.J., Porrino, L.J., 2011. Elevated gray and white
matter densities in cocaine abstainers compared to current users.
Psychopharmacology (Berl.) 218, 681–692.
Hanlon, C.A., Owens, M.M., Joseph, J.E., Zhu, X., George, M.S., Brady, K.T., Hartwell,
K.J., 2016. Lower subcortical gray matter volume in both younger smokers and es-
tablished smokers relative to non-smokers. Addict. Biol. 21, 185–195.
Heather, N., Gold, R., Rollnick, S., 1991. Readiness to Change Questionnaire: User’s
Manual. Kensington Australia Natl. Drug Alcohol Res. Centre, Univ. New South
Wales. https://ndarc.med.unsw.edu.au/resource/readiness-change-questionnaire-
users-manual. (Accessed 9 April 2018).
Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerstrom, K., 1991. The fagerstrom test
for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br. J.
Addict. 86, 1119–1127.
Ide, J.S., Zhang, S., Hu, S., Sinha, R., Mazure, C.M., Li, C.R., 2014. Cerebral gray matter
volumes and low-frequency ﬂuctuation of BOLD signals in cocaine dependence:
duration of use and gender diﬀerence. Drug Alcohol Depend. 134, 51–62.
Jansen, J.M., van Wingen, G., van den Brink, W., Goudriaan, A.E., 2015. Resting state
connectivity in alcohol dependent patients and the eﬀect of repetitive transcranial
magnetic stimulation. Eur. Neuropsychopharmacol. 25, 2230–2239.
Jutkiewicz, E.M., Nicolazzo, D.M., Kim, M.N., Gnegy, M.E., 2008. Nicotine and amphe-
tamine acutely cross-potentiate their behavioral and neurochemical responses in fe-
male Holtzman rats. Psychopharmacology (Berl.) 200, 93–103.
Kaag, A.M., Crunelle, C.L., van Wingen, G., Homberg, J., van den Brink, W., Reneman, L.,
2014. Relationship between trait impulsivity and cortical volume, thickness and
surface area in male cocaine users and non-drug using controls. Drug Alcohol
Depend. 144, 210–217.
Kaag, A.M., Lever, N., Woutersen, K., Homberg, J., van den Brink, W., Reneman, L., van
Wingen, G., 2016a. Hyper-responsiveness of the neural fear network during fear
A.M. Kaag et al. Drug and Alcohol Dependence 187 (2018) 186–194
193
conditioning and extinction learning in male cocaine users. Am. J. Psychiatry 173,
1033–1042.
Kaag, A.M., Wingen, G.A., Van Caan, M.W.A., Homberg, J.R., Van Den Brink, W.,
Reneman, L., 2016b. White matter alterations in cocaine users are negatively related
to the number of additionally (ab) used substances. Addict. Biol. 22, 1048–1056.
Lawyer, G., Bjerkan, P.S., Hammarberg, A., Jayaram-Lindström, N., Franck, J., Agartz, I.,
2010. Amphetamine dependence and co-morbid alcohol abuse: associations to brain
cortical thickness. BMC Pharmacol. 10, 5.
Liao, Y., Tang, J., Liu, T., Chen, X., Hao, W., 2012. Diﬀerences between smokers and non-
smokers in regional gray matter volumes: a voxel-based morphometry study. Addict.
Biol. 17, 977–980.
Lim, K.O., Wozniak, J.R., Mueller, B., Franc, D.T., Specker, S.M., Rodriguez, C.P.,
Silverman, A.B., Rotrosen, J.P., 2008. Brain macrostructural and microstructural
abnormalities in cocaine dependence. Drug Alcohol Depend. 92, 164–172.
Lopes, C.F.B., De Angelis, B.B., Prudente, H.M., De Souza, B.V.G., Cardoso, S.V., De
Azambuja Ribeiro, R.I.M., 2012. Concomitant consumption of marijuana, alcohol and
tobacco in oral squamous cell carcinoma development and progression: recent ad-
vances and challenges. Arch. Oral Biol. 57, 1026–1033.
Lopez-Larson, M.P., Bogorodzki, P., Rogowska, J., McGlade, E., King, J.B., Terry, J.,
Yurgelun-Todd, D., 2011. Altered prefrontal and insular cortical thickness in ado-
lescent marijuana users. Behav. Brain Res. 220, 164–172.
Mackey, S., Stewart, J.L., Connolly, C.G., Tapert, S.F., Paulus, M.P., 2014. A voxel-based
morphometry study of young occasional users of amphetamine-type stimulants and
cocaine. Drug Alcohol Depend. 135, 104–111.
Makris, N., Gasic, G.P., Kennedy, D.N., Hodge, S.M., Kaiser, J.R., Lee, M.J., Kim, B.W.,
Blood, A.J., Evins, A.E., Seidman, L.J., Iosifescu, D.V., Lee, S., Baxter, C., Perlis, R.H.,
Smoller, J.W., Fava, M., Breiter, H.C., 2008. Cortical thickness abnormalities in co-
caine addiction—a reﬂection of both drug use and a pre-existing disposition to drug
abuse? Neuron 60, 174–188.
Matochik, J.A., London, E.D., Eldreth, D.A., Cadet, J., Bolla, K.I., 2003. Frontal cortical
tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study.
Methods 19, 1095–1102.
Medina, K.L., Schweinsburg, A.D., Cohen-Zion, M., Nagel, B.J., Tapert, S.F., 2007. Eﬀects
of alcohol and combined marijuana and alcohol use during adolescence on hippo-
campal volume and asymmetry. Neurotoxicol. Teratol. 29, 141–152.
Moorman, D.E., James, M.H., McGlinchey, E.M., Aston-Jones, G., 2015. Diﬀerential roles
of medial prefrontal subregions in the regulation of drug seeking. Brain Res. 1628,
130–146.
Narayana, P.A., Datta, S., Tao, G., Steinberg, J.L., Moeller, F.G., 2010. Eﬀect of cocaine on
structural changes in brain: MRI volumetry using tensor-based morphometry. Drug
Alcohol Depend. 111, 191–199.
Netherlands Institute of Mental Health and Addiction, 2016. Nationale Drug Monitor
2016.
Peng, P., Wang, Z., Jiang, T., Chu, S., Wang, S., Xiao, D., 2015. Brain-volume changes in
young and middle-aged smokers: a DARTEL-based voxel-based morphometry study.
Clin. Respir. J. 11, 621–631.
Pennington, D.L., Durazzo, T.C., Schmidt, T.P., Abé, C., Mon, A., Meyerhoﬀ, D.J., 2015.
Alcohol use disorder with and without stimulant use: brain morphometry and its
associations with cigarette smoking, cognition, and inhibitory control. PLoS One 10,
e0122505.
Pierce, R.C., Kumaresan, V., 2006. The Mesolimbic Dopamine System: the ﬁnal common
pathway for the reinforcing eﬀect of drugs of abuse? Neurosci. Biobehav. Rev. 30,
215–238.
Rajapakse, J.C., Giedd, J.N., Rapoport, J.L., 1997. Statistical approach to segmentation of
single-channel cerebral MR images. IEEE Trans. Med. Imaging 16, 176–186.
Rando, K., Hong, K.-I., Bhagwagar, Z., Li, C.R., Bergquist, K.L., Guarnaccia, J., Sinha, R.,
2011. Association of frontal and posterior cortical gray matter volume with time to
alcohol relapse: a prospective study. Am. J. Psychiatry 168, 183–192.
Rando, K., Tuit, K., Hannestad, J., Guarnaccia, J., Sinha, R., 2013. Sex diﬀerences in
decreased limbic and cortical grey matter volume in cocaine dependence: a voxel-
based morphometric study. Addict. Biol. 18, 147–160.
Reid, A.G., Daglish, M.R., Kempton, M.J., Williams, T.M., Watson, B., Nutt, D.J., Lingford-
Hughes, A.R., 2008. Reduced thalamic grey matter volume in opioid dependence is
inﬂuenced by degree of alcohol use: a voxel-based morphometry study. J.
Psychopharmacol. 22, 7–10.
Ridderinkhof, K.R., 2004. The role of the medial frontal cortex in cognitive control.
Science 15, 443–447.
Robins, L.N., Wing, J., Wittchen, H.U., Helzer, J.E., Babor, T.F., Burke, J., Farmer, A.,
Jablenski, A., Pickens, R., Regier, D.A., 1988. The Composite International Diagnostic
Interview. An epidemiologic Instrument suitable for use in conjunction with diﬀerent
diagnostic systems and in diﬀerent cultures. Arch. Gen. Psychiatry 45, 1069–1077.
Roebuck, M.C., French, M.T., Dennis, M.L., 2004. Adolescent marijuana use and school
attendance. Econ. Educ. Rev. 23, 133–141.
Schulte, M.H.J., Kaag, A.M., Wiers, R.W., Schmaal, L., van den Brink, W., Reneman, L.,
Homberg, J.R., van Wingen, G.A., Goudriaan, A.E., 2017. Prefrontal Glx and GABA
concentrations and impulsivity in cigarette smokers and smoking polysubstance
users. Drug Alcohol Depend. 179, 117–123.
Shiba, Y., Santangelo, A.M., Roberts, A.C., 2016. Beyond the medial regions of prefrontal
cortex in the regulation of fear and anxiety. Front. Syst. Neurosci. 10, 12.
Sobell, L., Sobell, M., 1992. Timeline follow-back. A technique for assessing self-reported
alcohol consumption. In: Litten, R.Z., Allen, J.P. (Eds.), Measuring Alcohol
Consumption. Humana Press, NJ, pp. 41–72.
Thayer, R.E., Hagerty, S.L., Sabbineni, A., Claus, E.D., Hutchison, K.E., Weiland, B.J.,
2016. Negative and interactive eﬀects of sex aging, and alcohol abuse on gray matter
morphometry. Hum. Brain Mapp. 37, 2276–2292.
Tohka, J., Zijdenbos, A., Evans, A., 2004. Fast and robust parameter estimation for sta-
tistical partial volume models in brain MRI. Neuroimage 23, 84–97.
Valjent, E., Mitchell, J.M., Besson, M.J., Caboche, J., Maldonado, R., 2002. Behavioural
and biochemical evidence for interactions between Δ9-tetrahydrocannabinol and
nicotine. Br. J. Pharmacol. 135, 564–578.
Wetherill, R.R., Jagannathan, K., Hager, N., Childress, A.R., Rao, H., Franklin, T.R., 2015.
Cannabis, cigarettes, and their co-occurring use: disentangling diﬀerences in gray
matter volume. Int. J. Neuropsychopharmacol. 18, pyv061.
Wheeler, R.A., Twining, R.C., Jones, J.L., Slater, J.M., Grigson, P.S., 2008. Article be-
havioral and electrophysiological indices of negative aﬀect predict cocaine self-ad-
ministration. Neuron 774–785.
Wonnacott, S., 1997. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20, 92–98.
Xiao, P., Dai, Z., Zhong, J., Zhu, Y., Shi, H., Pan, P., 2015. Regional gray matter deﬁcits in
alcohol dependence: a meta-analysis of voxel-based morphometry studies. Drug
Alcohol Depend. 153, 22–28.
Yang, X., Tian, F., Zhang, H., Zeng, J., Chen, T., Wang, S., Jia, Z., Gong, Q., 2016. Cortical
and subcortical gray matter shrinkage in alcohol-use disorders: a voxel-based meta-
analysis. Neurosci. Biobehav. Rev. 66, 92–103.
Yu, D., Yuan, K., Cheng, J., Guan, Y., Li, Y., Bi, Y., Zhai, J., Luo, L., Liu, B., Xue, T., Lu, X.,
2017. Reduced thalamus volume may reﬂect nicotine severity in young male smo-
kers. Nicotine Tob. Res. 1–6.
Zhong, J., Shi, H., Shen, Y., Dai, Z., Zhu, Y., Ma, H., Sheng, L., 2016. Voxelwise meta-
analysis of gray matter anomalies in chronic cigarette smokers. Behav. Brain Res.
311, 39–45.
Zubieta, J.K., Lombardi, U., Minoshima, S., Guthrie, S., Ni, L., Ohl, L.E., Koeppe, R.A.,
Domino, E.F., 2001. Regional cerebral blood ﬂow eﬀects of nicotine in overnight
abstinent smokers. Biol. Psychiatry 49, 906–913.
A.M. Kaag et al. Drug and Alcohol Dependence 187 (2018) 186–194
194
